UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053301
Receipt number R000060428
Scientific Title Open-label, exploratory clinical trial of electrical stimulation therapy for peroneus longus muscle in patients with hallux valgus
Date of disclosure of the study information 2024/01/09
Last modified on 2024/03/11 13:11:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of electrical stimulation therapy for peroneus longus muscle in patients with hallux valgus

Acronym

Electrical stimulation therapy of peroneus longus muscle for hallux valgus

Scientific Title

Open-label, exploratory clinical trial of electrical stimulation therapy for peroneus longus muscle in patients with hallux valgus

Scientific Title:Acronym

Electrical stimulation therapy of peroneus longus muscle for hallux valgus

Region

Japan


Condition

Condition

Hallux Valgus

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate the correction effects of electrical muscle stimulation on peroneus longus in patients with hallux valgus.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Hallux valgus angle on standing plain radiograph

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Electrical muscle stimulation of the peroneus longus muscle using low frequency treatment device

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

1. Patients who are at least 18 years of age and under 70 years of age at the time consent is obtained. (Male and female)
2. Patients who meet the diagnostic criteria of hallux valgus within one month before registration. (Hallux valgus angle less than 50 degrees)
3. Patients who can visit outpatient clinic for 28 weeks.
4. Patients who can provide written consent to participate in this study.

Key exclusion criteria

1. Patients who already performed physical therapy (strength training of the abductor hallucis muscle) within one month before registration.
2. Patients who have subluxation of the first metatarsophalangeal joint. (Hallux valgus angle over 50 degrees)
3. Patients who have dislocation of the lesser metatarsophalangeal joint.
4. Patients who have moderate flatfoot deformity. (Lateral talo-first metatarsal angle over 15 degrees)
5. Patients who take nonsteroidal anti-inflammatory drugs regularly within 4 weeks before registration.
6. History of cerebral vascular disease, neuromuscular disease, or hemiplegia.
7. History of serious side effects by low frequency treatment device.
8. Patients who meet the contraindication of the low frequency treatment device.
9. Women who are pregnant or may become pregnant, who are breastfeeding or who wish to become pregnant.
10. Patients who have participated or are willing to participate in other clinical trials during participation in the current study.
11. Patient who may suffer an unjust disadvantage by participating in this study, or disturbing the specific assessment in the current study.
12. Individuals who are investigator of the current study or employee of this hospital, or whose family.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Nobuo
Middle name
Last name Adachi

Organization

Hiroshima University Hospital

Division name

Department of Orthopaedic Surgery

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima

TEL

082-257-5470

Email

nadachi@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Yasunari
Middle name
Last name Ikuta

Organization

Hiroshima University Hospital

Division name

Department of Orthopaedic Surgery

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima

TEL

082-257-5470

Homepage URL


Email

yikuta@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee for Clinical Research of Hiroshima University

Address

Kasumi 1-2-3 Minami-Ku, Hiroshima

Tel

082-257-1947

Email

iryo-sinsa@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 11 Month 21 Day

Date of IRB

2023 Year 12 Month 15 Day

Anticipated trial start date

2024 Year 01 Month 29 Day

Last follow-up date

2026 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 01 Month 09 Day

Last modified on

2024 Year 03 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060428


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name